Hedge Funds Bought These 2 Stocks Hand-Over-Fist Last Quarter

-
UnitedHealth Group (UNH) has rebounded nearly 40% from its July lows after falling more than 60% from peak to trough.
-
UnitedHealth raised its full-year earnings forecast, but Deutsche Bank warned growth pressures will continue.
-
Nvidia (NVDA) remains a popular hedge fund buy despite recent volatility and retracement territory.
-
If you’re thinking about retiring or know someone who is, here are three quick questions that will make many Americans realize they may be retiring sooner than expected. take 5 minutes learn more here
Large hedge funds have mostly been net sellers of stocks in recent quarters. And while it may seem ominous that so many smart money managers have gone on record this year, I would argue that taking profits and directing capital to more defensive areas of the market is only wise. Of course, taking some capital out of risky AI trades for cheaper, less popular names comes with the risk of missing out on additional returns, especially if the bull market is strong and the AI trade heats up again.
While the smart money has been selling a lot lately, there have also been some opportunistic buys; I think this should attract the attention of value investors who are waiting for extra cash on the sidelines and not nearly enough ideas in this arguably expensive stock market.
Even if stocks are overdue for a course correction, you’ll probably still have value if you can find it. In this article, we’ll look at the three most popular picks from many major hedge funds in the third quarter.
If you follow a few smart money managers, you’ve likely seen some nibbling on stocks. United Health Group (NYSE:UNH). It became the hedge fund’s favorite in the last quarter as shares contracted sharply in both the first half of the year and the final quarter of last year. When a blue-chip Dow Jones Industrial Average component explodes more than 60% from peak to trough, such a move should grab your attention if you’re a value seeker.
In recent months, UnitedHealth Group’s shares have shown signs of settling in; This should be comforting for those who do not like to catch falling knives. With a nice rise of nearly 40% in the multi-year depths of July, UnitedHealth Group shares may finally be at an inflection point.
Despite a near 8% drop last month, the technical picture looks much better today. While the situation seems clear, investors may want to be cautious and gradual with a name like this, given the possibility that some dip buyers may be a little too optimistic about the company’s recovery prospects. The last quarter was good, and with earnings estimates for the full year being raised, it looks like the worst is already in sight. But it will take more than a quarter to reverse this brutal trend.



